The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

Arbidol (ARB) is a synthetic antiviral originally developed to combat influenza viruses. ARB is currently used clinically in several countries but not in North America. We have previously shown that ARB inhibits in vitro hepatitis C virus (HCV) by blocking HCV entry and replication. In this report,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Pécheur, Eve-Isabelle, Borisevich, Viktoriya, Halfmann, Peter, Morrey, John D., Smee, Donald F., Prichard, Mark, Mire, Chad E., Kawaoka, Yoshihiro, Geisbert, Thomas W., Polyak, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4810626/
https://ncbi.nlm.nih.gov/pubmed/26739045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02077-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados